9-136336996-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001145638.3(GPSM1):c.502G>A(p.Ala168Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000431 in 1,553,862 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001145638.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPSM1 | NM_001145638.3 | c.502G>A | p.Ala168Thr | missense_variant | 4/14 | ENST00000440944.6 | NP_001139110.2 | |
GPSM1 | NM_015597.6 | c.502G>A | p.Ala168Thr | missense_variant | 4/9 | NP_056412.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPSM1 | ENST00000440944.6 | c.502G>A | p.Ala168Thr | missense_variant | 4/14 | 5 | NM_001145638.3 | ENSP00000392828.1 | ||
GPSM1 | ENST00000616132.4 | c.502G>A | p.Ala168Thr | missense_variant | 4/9 | 1 | ENSP00000479405.1 | |||
GPSM1 | ENST00000354753.7 | c.598G>A | p.Ala200Thr | missense_variant | 4/14 | 5 | ENSP00000346797.4 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152168Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000499 AC: 8AN: 160170Hom.: 0 AF XY: 0.0000709 AC XY: 6AN XY: 84638
GnomAD4 exome AF: 0.0000442 AC: 62AN: 1401578Hom.: 0 Cov.: 32 AF XY: 0.0000564 AC XY: 39AN XY: 691690
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152284Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74458
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 30, 2023 | The c.502G>A (p.A168T) alteration is located in exon 4 (coding exon 4) of the GPSM1 gene. This alteration results from a G to A substitution at nucleotide position 502, causing the alanine (A) at amino acid position 168 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at